General News

RMS Receives FDA Clearance for 510(k)

RMS Freedom Infusion System Cleared for Both Subcutaneous and Intravenous Indications CHESTER, NY / September 05, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announces the FDA issued a new 510(k) clearance for the RMS “Integrated Catch-Up Freedom Syringe Driver Infusion System” effective August 31, 2017.  The Freedom System is the … Continued

RMS Launches New Social Media Campaign

CHESTER, NY / May 15, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) announced today it will be launching a new social media marketing campaign at the National Home Infusion Association (NHIA) in Orlando Florida on May 22, 2017.  NHIA is one of the largest U.S. tradeshows … Continued

RMS Medical Products launches FREEDOM60® Infusion system in Germany

CHESTER, NY / April 10, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) is pleased to announce that the umbrella organization of the public health insurance in Germany approved the FREEDOM60® Infusion System for reimbursement. The FREEDOM60® System was registered January, 31st 2017 and listed in the … Continued

RMS Strengthens Global Sales Team

CHESTER, NY / April 3, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) announced today it has strengthened its Global Sales and Marketing team by hiring Steven Kamphausen as Global VP, Sales and Marketing.  Steve comes to us by way of Toyota Tsusho America from a senior … Continued

Investor Updates

8-K 5/22/17 – Change in Fiscal Year

On March 22, 2017, the Board of Directors of Repro Med Systems, Inc. (the “Company”) approved a change in the Company’s fiscal year end from February 28 to December 31.  This change is being made by the Company to better align the Company’s financial reporting calendar with its industry peers, suppliers and customers.  Accordingly, the … Continued

RMS Appoints New COO

On January 17, 2017, Repro Med Systems, Inc. dba RMS Medical Products (“RMS”) hired Mr. Eric Bauer as its Chief Operating Officer, effective immediately.

RMS Medical Products Posts Third Quarter 2017 Results

The Company announced that its net revenues for the third quarter ended November 30 of fiscal 2017 were $3,193,113 compared with $3,144,954 for the third quarter of fiscal 2016. Net loss for the quarter was $104,275 compared with net income of $167,552 for the same period last year. For the nine months ended November 30, … Continued